Trial intelligence / Profile preview

Raltitrexed and Radiotherapy in Older Patients with HNSCC

NCT03196843Phase 4Unknown

Sponsor
The First Affiliated Hospital of Dalian Medical University
Start
Sep 2017
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raltitrexed in head and neck squamous cell carcinoma (HNSCC), sponsored by The First Affiliated Hospital of Dalian Medical University. Status: unknown.

02

Drugs

raltitrexed
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT03196843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03196843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call